Press Releases

April 29, 2026  Press Release

Deployment across VA and Department of Defense systems brings Rapid Nexus into real-world clinical use, expanding access to its FDA-cleared Hemastyl® treatment for complex wound cases…

January 21, 2026  Press Release

The study reports that tissue previously considered beyond recovery — and slated for surgical amputation — was able to stabilize and heal when peripheral neuropathy was directly addressed through a targeted nerve signaling intervention…

November 13, 2025  Press Release

Rapid Nexus Nanotech Wound Solutions, Inc., a California-based med-tech company focused on advanced wound care, today announced it has received FDA 510(k) clearance for its Hemastyl gel device—marking a historic milestone as the first company to directly target the underlying reason chronic wounds fail to heal….

September 23, 2025  Press Release

This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who previously had no options…

Media Coverage & Latest Updates

Peer-reviewed study: Diabetic Mouse Delayed Wound Model Following Treatment with the NerveStim™ Neuropathy System

Delayed wound healing in diabetes is characterized by impaired angiogenesis, persistent inflammation, extracellular matrix dysregulation, and peripheral neuropathy. A preclinical study was conducted...

Peer-reviewed study: Diabetic Foot and Leg Ulcer & Peri-wound Neuropathy Healing Feasibility Studies

Diabetic foot and leg ulcers represent a significant global health burden and are frequently associated with peripheral neuropathy, vascular compromise, infection, and high rates of recurrence and...

Drug and Device World: Rapid Nexus charts a new path for chronic wounds

In the shadow of a global diabetes epidemic and an aging population, chronic wounds—diabetic foot ulcers, venous leg ulcers, pressure injuries—represent a silent, growing, and devastating healthcare...

Citeline: Rapid Nexus Bets On Regeneration To Heal Wounds, Stop Amputations, Starting In VA Health Systems

Rapid Nexus hopes its regenerative wound-healing system can ease the burden of diabetic foot ulcers and amputations. Backed by early clinical data and $3.8m in seed funding, the start-up is targeting...

Yahoo Finance: Rapid Nexus Unveils First-Ever Medical Technology to Regrow Nerves and Stop Amputations in Diabetic Patients

This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who...

Rapid Nexus Clinches 1st Place at PitchForce

Dr. Margaret Kalmeta was handpicked by a panel of seasoned investors as the 1st-place winner at PitchForce, where she delivered a compelling 4-minute pitch on Rapid Nexus Nanotech Wound Solutions...

Rapid Nexus Presents Hemastyl™ at Burn and Reconstructive Centers of America

Dr. Margaret Kalmeta had the privilege of serving as Keynote Speaker at the Burn and Reconstructive Centers of America, presenting Rapid Nexus’s innovative Peri-wound treatment, Hemastyl™. The...

Podcast Feature: Exploring Innovation in Wound Care

Dr. Margaret Kalmeta of Rapid Nexus Nanotech Wound Solutions, Inc. was recently featured on a podcast with Darwin Shurig at Shurig Solutions Inc., where she shared insights into the company’s...

LSI: Rapid Nexus Secures Two New Patents in Q2

Rapid Nexus Nanotech Wound Solutions, Inc. (hashtag#LSIEurope23 Innovator) received two additional patents in Q2, bringing their total number of patents to four U.S. issued patents and six...

Want to get involved?